Journal
/
Cancer Research
/
分析EGFR突变型NSCLC患者衍生类器官靶向治疗的敏感性
JoVE Journal
Cancer Research
This content is Free Access.
JoVE Journal Cancer Research
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Please note that all translations are automatically generated. Click here for the English version.

分析EGFR突变型NSCLC患者衍生类器官靶向治疗的敏感性

3,451 Views

•

08:52 min

•

November 22, 2021

DOI:

10.3791/63039-v

DOI:
10.3791/63039-v

•

08:52 min
November 22, 2021

•

2 Views
, , ,
1Department of Medicine,University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center,University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology,University of California, San Francisco

Tags

OrganoidsEGFR-mutant NSCLCTargeted TherapiesMatrigelCell CultureDissociationTrypsinizationCentrifugationCell CountingCell Suspension96-well Plate

Read Article

Cite this Article

Barbosa Rabago, D., Blakely, C. M., Haderk, F., Bivona, T. G. Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids. J. Vis. Exp. (177), e63039, doi:10.3791/63039 (2021).

Download .ris file

Copy

Share Video

.

Copy